Skip to main content
Navigate Up
Sign In
 

Novartis outlines more steps to contain fallout from payments to Trump’s lawyers


​Amid the fallout over the $1.2 million payments to President Trump’s personal attorney, Novartis is trying to move quickly to contain the damage.

In the past 24 hours, the drug maker’s former chief executive publicly accepted responsibility for faulty judgment in trying to gain access to the Trump administration. And the chief lawyer has resigned for being a party to the contract signed with Michael Cohen.

However, during a previously scheduled presentation to analysts and investors today, the company also made a point of flashing a slide entitled “Beginning our journey to rebuild trust with society,” which listed a half-dozen steps being taken to restore confidence in management (see page 13).